Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Bumetanide in Patients With Alzheimer's Disease — Stella

Home/Alzheimer Disease/Bumetanide in Patients With Alzheimer's Disease

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease trials

Bumetanide in Patients With Alzheimer's Disease

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Stanford University, Stanford, California

Key details

Phase

Safety & dosing

Sponsor

Stanford University

Enrollment target

~40 participants

Started

April 2023

Primary completion

December 2026

Age range

50 Years – 85 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.